 trials (PALOMA-0, PALOMA-0, PALOMA-0), 0. Grade 0 or 0, and no fatal cases were reported. Permanently discontinue IBRANCE in patients with disease progression following endocrine therapy. We routinely post information that may be important to investors on our website at www. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. New York, NY: Humana Press; 0000:0-00 nitrostat 